Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein
- 10 April 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (6) , 867-877
- https://doi.org/10.1089/hum.1998.9.6-867
Abstract
Neointimal formation involving smooth muscle cell (SMC) migration and proliferation is a common feature of atherosclerosis, restenosis after angioplasty, and vein graft intimal thickening. Extracellular matrix remodeling by metalloproteinase (MMP) enzymes is an essential component of neointimal formation and therefore MMPs are a potential target for localized gene therapy. To evaluate this concept using human tissue, we used the highly reproducible organ culture model of neointimal formation in human saphenous vein to investigate the effect of adenovirus-mediated gene transfer of tissue inhibitor of metalloproteinase 1 (TIMP-1) and the bacterial LacZ gene (RAd35) as a control. Incubating veins with 100 μl of RAd35 (1.2 × 1010 pfu/ml) led to expression of LacZ in 39 ± 7% of surface cells but had no effect on SMC proliferation, migration, or neointimal formation. Similar infection with RAdTIMP-1 increased explanation of TIMP-1 in surface cells and significantly inhibited neointimal formation and SMC migration after 14 days by 54% and 78%, respectively (n = 6, p < 0.05 Student's paired t test). No effect on SMC proliferation or deleterious effect on cell viability was observed. A specific MMP inhibitory effect was detected using in situ zymography. These data confirm the importance of MMPs in neointimal formation and highlight the potential for application of TIMP gene therapy. We tested the concept that adenovirus-mediated gene transfer of a tissue inhibitor of matrix-degrading metalloproteinases (TIMP-1) would inhibit neointimal formation in human saphenous vein segments in organ culture. We achieved efficient infection and expression in lumenal cells of the human TIMP-1 gene and bacterial LacZ gene as a control. TIMP-1 expression significantly reduced SMC migration and neointimal formation but not SMC proliferation or cell viability. This study demonstrates the importance of MMP activity in neointimal formation and supports the potential application of TIMP-1 in gene therapy.Keywords
This publication has 34 references indexed in Scilit:
- Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cellsMatrix Biology, 1996
- The recombinant catalytic domain of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP‐2FEBS Letters, 1996
- Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2FEBS Letters, 1996
- Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.Journal of Clinical Investigation, 1996
- An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitroAtherosclerosis, 1996
- Antisense Oligonucleotides to the P65 Subunit of NF-κb Inhibit Human Vascular Smooth Muscle Cell Adherence and Proliferation and Prevent Neointima Formation in Rat Carotid ArteriesBiochemical and Biophysical Research Communications, 1995
- Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.Journal of Clinical Investigation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Recombinant Gene Expression in Vivo Within Endothelial Cells of the Arterial WallScience, 1989